Literature DB >> 19372387

Neuritogenic actions of botulinum neurotoxin A on cultured motor neurons.

Julie A Coffield1, Xiuzhen Yan.   

Abstract

Botulinum neurotoxins (BoNTs) are extremely potent neuromuscular poisons that act through soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein cleavage to inhibit neurotransmitter release. The ability of BoNT serotype A (BoNT/A) to eliminate localized transmitter release at extremely low doses is well characterized. In the current study, we investigated the less understood characteristic of BoNT/A to induce nerve outgrowth, sometimes referred to as sprouting. This phenomenon is generally considered a secondary response to the paralytic actions of BoNT/A, and other potential factors that may initiate this sprouting have not been investigated. Alternatively, we hypothesized that BoNT/A induces sprouting through presynaptic receptor activation that is independent of its known intracellular actions on the soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) synaptosomal associated protein of 25 kDa (SNAP-25). To test this, the effects of BoNT/A application on neurite outgrowth were examined using primary cultures enriched with motor neurons isolated from embryonic mouse spinal cord. In this system, BoNT/A potently stimulated neuritogenesis at concentrations as low as 0.01 nM. The neuritogenic effects of BoNT/A exposure were concentration dependent and antagonized by Triticum vulgaris lectin, a known competitive antagonist of BoNT. Similar results were observed with the isolated BoNT/A binding domain, revealing that neuritogenesis could be initiated solely by the binding actions of BoNT/A. In addition, the presence or absence of SNAP-25 cleavage by BoNT/A was not a determinant factor in BoNT/A-induced neuritogenesis. Collectively, these results suggest that binding of BoNT/A to the motor neuronal membrane activates neuritogenesis through as yet undetermined intracellular pathway(s), independent of its known action on vesicular release.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372387      PMCID: PMC2700173          DOI: 10.1124/jpet.108.147744

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  38 in total

1.  Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation.

Authors:  Frédéric A Meunier; Godfrey Lisk; Dorothea Sesardic; J Oliver Dolly
Journal:  Mol Cell Neurosci       Date:  2003-04       Impact factor: 4.314

Review 2.  Regulation of growth cone extension by SNARE proteins.

Authors:  Kazushi Kimura; Akira Mizoguchi; Chizuka Ide
Journal:  J Histochem Cytochem       Date:  2003-04       Impact factor: 2.479

3.  Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones.

Authors:  G Ahnert-Hilger; M Höltje; G Grosse; G Pickert; C Mucke; B Nixdorf-Bergweiler; P Boquet; F Hofmann; I Just
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

Review 4.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

5.  Isolation and culture of motor neurons from the newborn mouse spinal cord.

Authors:  Kirstie N Anderson; Allyson C Potter; Loretta G Piccenna; Alvin K J Quah; Kay E Davies; Surindar S Cheema
Journal:  Brain Res Brain Res Protoc       Date:  2004-02

Review 6.  Enhancing and regulating neurite outgrowth.

Authors:  Edward J Calabrese
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

Review 7.  Botulinum toxin as a biological weapon: medical and public health management.

Authors:  S S Arnon; R Schechter; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; J Hauer; M Layton; S Lillibridge; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; D L Swerdlow; K Tonat
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

Review 8.  Ganglioside function in calcium homeostasis and signaling.

Authors:  Robert W Ledeen; Gusheng Wu
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

9.  Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.

Authors:  S Kalandakanond; J A Coffield
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

Review 10.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

View more
  12 in total

Review 1.  Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery.

Authors:  Erkan Kiris; Krishna P Kota; James C Burnett; Veronica Soloveva; Christopher D Kane; Sina Bavari
Journal:  Expert Rev Mol Diagn       Date:  2014-01-23       Impact factor: 5.225

2.  SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons.

Authors:  Erkan Kiris; James C Burnett; Jonathan E Nuss; Laura M Wanner; Brian D Peyser; Hao T Du; Glenn Y Gomba; Krishna P Kota; Rekha G Panchal; Rick Gussio; Christopher D Kane; Lino Tessarollo; Sina Bavari
Journal:  Neurotox Res       Date:  2015-03-18       Impact factor: 3.911

3.  Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery.

Authors:  Erkan Kiris; Jonathan E Nuss; James C Burnett; Krishna P Kota; Dawn C Koh; Laura M Wanner; Edna Torres-Melendez; Rick Gussio; Lino Tessarollo; Sina Bavari
Journal:  Stem Cell Res       Date:  2011-01-19       Impact factor: 2.020

4.  Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays.

Authors:  Erkan Kiris; Jonathan E Nuss; Stephanie M Stanford; Laura M Wanner; Lisa Cazares; Michael F Maestre; Hao T Du; Glenn Y Gomba; James C Burnett; Rick Gussio; Nunzio Bottini; Rekha G Panchal; Christopher D Kane; Lino Tessarollo; Sina Bavari
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

5.  Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative.

Authors:  Jacob M Scherf; Xiaoyang Serene Hu; William H Tepp; Konstantin Ichtchenko; Eric A Johnson; Sabine Pellett
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

Review 6.  Therapeutic use of botulinum toxin in pain treatment.

Authors:  Raj Kumar
Journal:  Neuronal Signal       Date:  2018-08-31

7.  Neurotrophic effects of Botulinum neurotoxin type A in hippocampal neurons involve activation of Rac1 by the non-catalytic heavy chain (HCC/A).

Authors:  Luis Solabre Valois; Vanilla Hua Shi; Paul Bishop; Bangfu Zhu; Yasuko Nakamura; Kevin A Wilkinson; Jeremy M Henley
Journal:  IBRO Neurosci Rep       Date:  2021-05-13

8.  The Effect of Botulinum Neurotoxin Serotype a Heavy Chain on the Growth Related Proteins and Neurite Outgrowth after Spinal Cord Injury in Rats.

Authors:  Ya-Fang Wang; Fu Liu; Jing Lan; Juan Bai; Xia-Qing Li
Journal:  Toxins (Basel)       Date:  2018-02-02       Impact factor: 4.546

9.  Noncanonical Adult Human Neurogenesis and Axonal Growth as Possible Structural Basis of Recovery From Traumatic Vegetative State.

Authors:  Yulia Vainshenker; Vsevolod Zinserling; Alexander Korotkov; Svyatoslav Medvedev
Journal:  Clin Med Insights Case Rep       Date:  2017-09-25

10.  Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with Rats.

Authors:  Veronica Antipova; Andreas Wree; Carsten Holzmann; Teresa Mann; Nicola Palomero-Gallagher; Karl Zilles; Oliver Schmitt; Alexander Hawlitschka
Journal:  Toxins (Basel)       Date:  2018-07-17       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.